乳腺癌干细胞：身份错认？ - Suppr

Suppr

超能文献

Breast cancer stem cells: a case of mistaken identity?

作者信息

Polyak Kornelia

机构信息

Department of Medical Oncology, Dana-Farber Cancer Institute, 44 Binney Street, Boston, MA 02115, USA.

出版信息

Stem Cell Rev. 2007 Jun;3(2):107-9. doi: 10.1007/s12015-007-0020-8.

DOI:10.1007/s12015-007-0020-8

PMID:17873341

Abstract

摘要

相似文献

Breast cancer stem cells: a case of mistaken identity?

Stem Cell Rev. 2007 Jun;3(2):107-9. doi: 10.1007/s12015-007-0020-8.

Breast cancer stem cells: the other side of the story.

Stem Cell Rev. 2007 Jun;3(2):110-2; discussion 113. doi: 10.1007/s12015-007-0016-4.

Breast cancer stem cells-research opportunities utilizing mathematical modeling.

Stem Cell Rev. 2007 Jun;3(2):176-82. doi: 10.1007/s12015-007-0026-2.

Molecular Profiling and Malignant Behavior Define Two Rat Mammary Tumor Cell Lines as a Relevant Experimental Model.

J Cell Biochem. 2016 Dec;117(12):2825-2834. doi: 10.1002/jcb.25594. Epub 2016 Jun 3.

Modelling molecular mechanisms of breast cancer and invasion: lessons from the normal gland.

Biochem Soc Trans. 2007 Feb;35(Pt 1):18-22. doi: 10.1042/BST0350018.

The Emerging Picture of Human Breast Cancer as a Stem Cell-based Disease.

Stem Cell Rev. 2008 Summer;4(2):67-79. doi: 10.1007/s12015-008-9012-6.

The macrophage-stimulating protein pathway promotes metastasis in a mouse model for breast cancer and predicts poor prognosis in humans.

Proc Natl Acad Sci U S A. 2007 May 1;104(18):7570-5. doi: 10.1073/pnas.0702095104. Epub 2007 Apr 24.

[Beyond the brain: huntingtin in breast cancers].

Med Sci (Paris). 2016;32(8-9):674-7. doi: 10.1051/medsci/20163208005. Epub 2016 Sep 12.

Proteome of metastatic canine mammary carcinomas: similarities to and differences from human breast cancer.

J Proteome Res. 2010 Dec 3;9(12):6380-91. doi: 10.1021/pr100671c. Epub 2010 Nov 2.

Signal transduction in transgenic mouse models of human breast cancer--implications for human breast cancer.

J Mammary Gland Biol Neoplasia. 2008 Sep;13(3):323-35. doi: 10.1007/s10911-008-9087-3. Epub 2008 Jul 24.

引用本文的文献

Exploiting Cancer Cells Metabolic Adaptability to Enhance Therapy Response in Cancer.

Adv Exp Med Biol. 2020;1219:297-310. doi: 10.1007/978-3-030-34025-4_15.

Cancer Stem and Progenitor-Like Cells as Pharmacological Targets in Breast Cancer Treatment.

Breast Cancer (Auckl). 2015 Nov 12;9(Suppl 2):45-55. doi: 10.4137/BCBCR.S29427. eCollection 2015.

The first five years of single-cell cancer genomics and beyond.

Genome Res. 2015 Oct;25(10):1499-507. doi: 10.1101/gr.191098.115.

Cancer research meets evolutionary biology.

Evol Appl. 2009 Feb;2(1):62-70. doi: 10.1111/j.1752-4571.2008.00063.x.

Established breast cancer stem cell markers do not correlate with in vivo tumorigenicity of tumor-initiating cells.

Int J Oncol. 2012 Dec;41(6):1932-42. doi: 10.3892/ijo.2012.1654. Epub 2012 Oct 5.

Tracing the tumor lineage.

Mol Oncol. 2010 Jun;4(3):267-83. doi: 10.1016/j.molonc.2010.04.010. Epub 2010 May 5.

Breast cancer stem cell hypothesis: clinical relevance (answering breast cancer clinical features).

Clin Transl Oncol. 2010 Jun;12(6):395-400. doi: 10.1007/s12094-010-0526-4.

Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients.

Breast Cancer Res. 2009;11(4):R46. doi: 10.1186/bcr2333. Epub 2009 Jul 9.

ALDH1 expression correlates with favorable prognosis in ovarian cancers.

Mod Pathol. 2009 Jun;22(6):817-23. doi: 10.1038/modpathol.2009.35. Epub 2009 Mar 27.

Tumor-initiating cells and treatment resistance: how goes the war?

J Mammary Gland Biol Neoplasia. 2009 Mar;14(1):1-2. doi: 10.1007/s10911-009-9112-1. Epub 2009 Feb 24.

本文引用的文献

Molecular definition of breast tumor heterogeneity.

Cancer Cell. 2007 Mar;11(3):259-73. doi: 10.1016/j.ccr.2007.01.013.

Basal-like grade III invasive ductal carcinoma of the breast: patterns of metastasis and long-term survival.

Breast Cancer Res. 2007;9(1):R4. doi: 10.1186/bcr1636.

Cancer as an evolutionary and ecological process.

Nat Rev Cancer. 2006 Dec;6(12):924-35. doi: 10.1038/nrc2013. Epub 2006 Nov 16.

Cancer stem cells: an old idea--a paradigm shift.

Cancer Res. 2006 Feb 15;66(4):1883-90; discussion 1895-6. doi: 10.1158/0008-5472.CAN-05-3153.

Prospective identification of tumorigenic breast cancer cells.

Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):3983-8. doi: 10.1073/pnas.0530291100. Epub 2003 Mar 10.

Stem cells, cancer, and cancer stem cells.

Nature. 2001 Nov 1;414(6859):105-11. doi: 10.1038/35102167.

Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell.

Nat Med. 1997 Jul;3(7):730-7. doi: 10.1038/nm0797-730.

The clonal evolution of tumor cell populations.

Science. 1976 Oct 1;194(4260):23-8. doi: 10.1126/science.959840.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Breast cancer stem cells: a case of mistaken identity?

Stem Cell Rev. 2007 Jun;3(2):107-9. doi: 10.1007/s12015-007-0020-8.

Breast cancer stem cells: the other side of the story.

Stem Cell Rev. 2007 Jun;3(2):110-2; discussion 113. doi: 10.1007/s12015-007-0016-4.

Breast cancer stem cells-research opportunities utilizing mathematical modeling.

Stem Cell Rev. 2007 Jun;3(2):176-82. doi: 10.1007/s12015-007-0026-2.

Molecular Profiling and Malignant Behavior Define Two Rat Mammary Tumor Cell Lines as a Relevant Experimental Model.

J Cell Biochem. 2016 Dec;117(12):2825-2834. doi: 10.1002/jcb.25594. Epub 2016 Jun 3.

Modelling molecular mechanisms of breast cancer and invasion: lessons from the normal gland.

Biochem Soc Trans. 2007 Feb;35(Pt 1):18-22. doi: 10.1042/BST0350018.

The Emerging Picture of Human Breast Cancer as a Stem Cell-based Disease.

Stem Cell Rev. 2008 Summer;4(2):67-79. doi: 10.1007/s12015-008-9012-6.

The macrophage-stimulating protein pathway promotes metastasis in a mouse model for breast cancer and predicts poor prognosis in humans.

Proc Natl Acad Sci U S A. 2007 May 1;104(18):7570-5. doi: 10.1073/pnas.0702095104. Epub 2007 Apr 24.

[Beyond the brain: huntingtin in breast cancers].

Med Sci (Paris). 2016;32(8-9):674-7. doi: 10.1051/medsci/20163208005. Epub 2016 Sep 12.

Proteome of metastatic canine mammary carcinomas: similarities to and differences from human breast cancer.

J Proteome Res. 2010 Dec 3;9(12):6380-91. doi: 10.1021/pr100671c. Epub 2010 Nov 2.

Signal transduction in transgenic mouse models of human breast cancer--implications for human breast cancer.

J Mammary Gland Biol Neoplasia. 2008 Sep;13(3):323-35. doi: 10.1007/s10911-008-9087-3. Epub 2008 Jul 24.

引用本文的文献

Exploiting Cancer Cells Metabolic Adaptability to Enhance Therapy Response in Cancer.

Adv Exp Med Biol. 2020;1219:297-310. doi: 10.1007/978-3-030-34025-4_15.

Cancer Stem and Progenitor-Like Cells as Pharmacological Targets in Breast Cancer Treatment.

Breast Cancer (Auckl). 2015 Nov 12;9(Suppl 2):45-55. doi: 10.4137/BCBCR.S29427. eCollection 2015.

The first five years of single-cell cancer genomics and beyond.

Genome Res. 2015 Oct;25(10):1499-507. doi: 10.1101/gr.191098.115.

Cancer research meets evolutionary biology.

Evol Appl. 2009 Feb;2(1):62-70. doi: 10.1111/j.1752-4571.2008.00063.x.

Established breast cancer stem cell markers do not correlate with in vivo tumorigenicity of tumor-initiating cells.

Int J Oncol. 2012 Dec;41(6):1932-42. doi: 10.3892/ijo.2012.1654. Epub 2012 Oct 5.

Tracing the tumor lineage.

Mol Oncol. 2010 Jun;4(3):267-83. doi: 10.1016/j.molonc.2010.04.010. Epub 2010 May 5.

Breast cancer stem cell hypothesis: clinical relevance (answering breast cancer clinical features).

Clin Transl Oncol. 2010 Jun;12(6):395-400. doi: 10.1007/s12094-010-0526-4.

Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients.

Breast Cancer Res. 2009;11(4):R46. doi: 10.1186/bcr2333. Epub 2009 Jul 9.

ALDH1 expression correlates with favorable prognosis in ovarian cancers.

Mod Pathol. 2009 Jun;22(6):817-23. doi: 10.1038/modpathol.2009.35. Epub 2009 Mar 27.

Tumor-initiating cells and treatment resistance: how goes the war?

J Mammary Gland Biol Neoplasia. 2009 Mar;14(1):1-2. doi: 10.1007/s10911-009-9112-1. Epub 2009 Feb 24.

本文引用的文献

Molecular definition of breast tumor heterogeneity.

Cancer Cell. 2007 Mar;11(3):259-73. doi: 10.1016/j.ccr.2007.01.013.

Basal-like grade III invasive ductal carcinoma of the breast: patterns of metastasis and long-term survival.

Breast Cancer Res. 2007;9(1):R4. doi: 10.1186/bcr1636.

Cancer as an evolutionary and ecological process.

Nat Rev Cancer. 2006 Dec;6(12):924-35. doi: 10.1038/nrc2013. Epub 2006 Nov 16.

Cancer stem cells: an old idea--a paradigm shift.

Cancer Res. 2006 Feb 15;66(4):1883-90; discussion 1895-6. doi: 10.1158/0008-5472.CAN-05-3153.

Prospective identification of tumorigenic breast cancer cells.

Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):3983-8. doi: 10.1073/pnas.0530291100. Epub 2003 Mar 10.

Stem cells, cancer, and cancer stem cells.

Nature. 2001 Nov 1;414(6859):105-11. doi: 10.1038/35102167.

Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell.

Nat Med. 1997 Jul;3(7):730-7. doi: 10.1038/nm0797-730.

The clonal evolution of tumor cell populations.

Science. 1976 Oct 1;194(4260):23-8. doi: 10.1126/science.959840.